News

S

How iterative analysis of subject recruitment data can optimize outcomes during ongoing enrollment.

CRO/Sponsor: High Performing Study Startups Sites: RBM Challenges, Opportunities Trial Design: Three-pronged Monitoring Approach Study Recruitment: Enhancing Trial Enrollment Also in this issue: New EU Drug Legislation The Patient Experience Rebranding RBM

Drug development in oncology has some of the lowest rates of success and clinical trials in oncology are difficult because of recruitment, challenging protocols and multiple technologies used to evaluate drugs in trials. This eBook contains information on these challenges including Phase I trials, to improving recruitment and trends in oncology clinical trials.

This commemorative e-book includes special articles, as well as DIA session highlights and news that pharmaceutical and clinical trial professionals will find important and informative.

NAPF is launching its Project Innovation, a national movement to accelerate the pace of cancer medical discovery.

Project Innovation Launched to Drive Action

The WIRB-Copernicus Group announced it has formed a new cancer-focused institutional review board, WCG Oncology.

inVentiv Health Clinical and Advaxis, Inc. announced they have entered into a global master services agreement...

The WIRB-Copernicus Group announced today the formation of a new cancer-focused institutional review board, WCG Oncology

Redacted policy on sharing drug trial data in Europe.

If the EMA also stops releasing data on old trials, everybody will be kept even more in the dark, according to an editorial posted by bmj.com on May 28.

Celerion and the Korean Drug Development Fund announced a formal collaboration

Jean Burns shared experiences with me that offer important insights for government and industry funded clinical research sponsors to consider as they look to improve their partnership with study volunteers.

Celerion and the Korean Drug Development Fund announced a formal collaboration

INC Research announced a two-year partnership with the Society for Clinical Research Sites.

Effective clinical trial management depends on accurate and unbiased performance measurement.

Partnership reinforces sites' pivotal role in clinical development, demonstrates Company's on-going commitment to fostering strong site

Thomson Reuters Cortellis Competitive Intelligence

Novartis, Janssen, Merck (MSD outside the United States and Canada), Lilly, and Pfizer have joined with DrugDev in hosting a repository of specific investigator information as part of the Investigator Databank.

While adaptive trial designs have been slow to gain traction, there a many benefits to adopting this trial model.

PCI will be hosting the latest in their Global Clinical Trial Services Seminar Series in Oxford, England on June 18, 2014.

PRA announced it has completed its 20th first in human trial with biologics.

Investments, acquisitions in biotechnology, valuation, and regulatory innovation were main themes at the 2014 NewYorkBIO Conference.

Clinverse, Inc. and eClinical Insights announced today they have formed a strategic partnership.

Kenneth Getz spoke to Applied Clinical Trials about his book, as well as the changes in clinical trials since the first edition.

Clinverse and eClinical Insights announced a strategic partnership.